Spero Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Spero Therapeutics, Inc. (SPRO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $217.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $217.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $561.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.03M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.62M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $217.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $561.00K 10-K · filed 2025-03-27 |
| 2023-12-31 | $1.03M 10-K · filed 2024-03-13 |
| 2022-12-31 | $1.62M 10-K · filed 2023-03-30 |
| 2021-12-31 | $2.29M 10-K · filed 2022-03-31 |
| 2020-12-31 | $3.04M 10-K · filed 2021-03-11 |
| 2020-09-30 | $3.23M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.38M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.52M 10-K · filed 2020-03-16 |
| 2019-09-30 | $1.83M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.96M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.10M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |